Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $89.72M. Across the group, the median move over the past trading day is −0.49%. Price change over the past year runs from −62.1% to +15.8% across the middle 80 percent of the group, with a median of −12.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +1.34% | Sep 17, 2026 |
| ANIX | Anixa Biosciences, Inc. | $123.16M | Small cap | +22.00% | Sep 9, 2026 |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% | Sep 2, 2026 |
| BLRX | BioLineRx Ltd. | $12.45M | Micro cap | −25.97% | Aug 31, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.